Invenia is a specialized medical imaging brand from GE HealthCare, known for its Automated Breast Ultrasound (ABUS) systems designed for cancer screening.
Invenia is a specialized medical imaging product line developed by GE HealthCare, primarily recognized for its advanced Automated Breast Ultrasound (ABUS) systems. The Invenia ABUS is specifically designed as an FDA-approved supplemental screening tool aimed at detecting breast cancer in women with dense breast tissue, scenarios where traditional mammography may miss underlying conditions. By integrating 3D ultrasound technology, Invenia systems enhance early detection rates and support a proactive, multi-modality approach to patient breast care.
Empowering healthcare providers in comprehensive breast centers and diagnostic practices, Invenia ABUS delivers non-invasive, efficient, and reproducible imaging. The technology helps minimize the manual dependency of standard handheld ultrasounds while improving workflow, maximizing patient throughput, and significantly boosting clinical diagnostic confidence.
Leabhraichean-làimhe as ùire bho manuals+ air a thaghadh airson a’ bhrand seo.
Ceistean cumanta mu leabhraichean-làimhe, clàradh, agus taic airson a’ bhrand seo.
Invenia ABUS (Automated Breast Ultrasound) is an advanced medical imaging system developed by GE HealthCare. It is designed specifically as an FDA-approved supplemental screening tool for detecting breast cancer in women with dense breast tissue.
Operating manuals, clinical guidelines, best practices, and service instructions for Invenia ABUS systems can be found on this page or requested directly through the GE HealthCare customer support portal.
Mammography can sometimes miss cancers that are hidden by dense breast tissue. Incorporating Invenia ABUS as a supplemental screening tool significantly improves the early detection of mammographically occult, invasive cancers without relying on ionizing radiation.